Needham Initiates Coverage On Carlsmed with Buy Rating, Announces Price Target of $17
Needham analyst David Saxon initiates coverage on Carlsmed (NASDAQ: CARL ) with a Buy rating and announces Price Target of $17.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.